Those responsible for the clinical trial Recovery on hydroxychloroquine announced on Friday that this drug, considered as a possible treatment against Covid-19, does not show "any beneficial effect". on patients with the disease. This announcement comes a few days after the imbroglio around the controversial study published in the journal The Lancet. & Nbsp;
Those responsible for the clinical trial Recovery on hydroxychloroquine announced Friday that this drug, considered as a possible treatment against Covid-19, did not show "no beneficial effect" on patients suffering from the disease. This announcement comes a few days after the imbroglio around the controversial study published in the journal The Lancet. Hydroxychloroquine shows "no beneficial effect" for Covid-19 patients, according to officials of the British clinical trial Recovery who announced in a press release the "immediate" cessation of the inclusion of new patients for this treatment.
>> LIVE - Coronavirus: follow the evolution of the situation Friday June 5
Recovery, a major clinical trial whose results were eagerly awaited, was one of the only ones not to have suspended its tests on hydroxychloroquine after a controversial study of the Lancet, since withdrawn, which pointed to the ineffectiveness or even the harmful effect of the controversial molecule.
>> More information to follow ...
